Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-131 iobenguane SPECT imaging for diagnosis of pheochromocytoma/paraganglioma
CTR20180839Phase 3Active
- Sponsor
- Atom Hi-Tech
- Start
- Oct 2018
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Beta-minus Emitters → Radiopharmaceuticals, Gamma Emitters → Radiopharmaceuticals
- Countries
- 1
01
Overview
A Phase 3 trial of Iobenguane I-131 in pheochromocytoma, Paraganglioma (PGL), sponsored by Atom Hi-Tech. Started Oct 2018; status: active.
02
Drugs
Iobenguane I-131
03
Conditions
pheochromocytomaParaganglioma (PGL)
Beyond the preview
Go deeper on CTR20180839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180839.